title: The CCKA receptor antagonist SR 27897 differentially influences the activity of A9 and A10 dopaminergic neurons in the rat.
authors.affiliation: Department of Neuropsychiatry, Sanofi Recherche, Montpellier, France.
authors.forename: V
authors.initials: V
authors.lastname: Santucci
authors.forename: C
authors.initials: C
authors.lastname: Gueudet
authors.forename: O
authors.initials: O
authors.lastname: Thurneyssen
authors.forename: D
authors.initials: D
authors.lastname: Gully
authors.forename: P
authors.initials: P
authors.lastname: Soubrie
authors.forename: G
authors.initials: G
authors.lastname: Le Fur
mesh_terms: D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology; D020109:Devazepide; D004298:Dopamine / Q000378:metabolism*; D007210:Indoleacetic Acids / Q000494:pharmacology*; D008297:Male; D008636:Mesencephalon / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*; D012844:Sincalide / Q000494:pharmacology*; D013844:Thiazoles / Q000494:pharmacology*
chemical_list: D001570:Benzodiazepinones; D007210:Indoleacetic Acids; D011949:Receptors, Cholecystokinin; D013844:Thiazoles; C080460:SR 27897; D020109:Devazepide; D012844:Sincalide; D001058:Apomorphine; D004298:Dopamine